Last Updated: September 26, 2023 @ 9:13 am | ||
93697 | HPV 16 & 18/45 Genotype | |
Specimen: | Collect: |
|
Submit: |
| |
Special Handling: |
| |
Rejection Criteria: |
| |
Stability: | Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: Unacceptable; Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Monday, Wednesday | |
Reported: | 3-6 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | Please see report for interpretive data. The Aptima HPV 16 18/45 is an in vitro nuclei acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) of the human papillomavirus (HPV) types 16, 18, and 45 in cervical specimens from women with Aptima HPV Assay positive results. The Assay can differentiate HPV 16 from HPV 18 and/or 45, but does not differentiate between HPV 18 and HPV 45. The analytical performance characteristics of this assay, when used to test Surepath specimens, have been determined by Medical Lab Associates. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.